104 related articles for article (PubMed ID: 3701955)
1. Polysorbates and renal oxalate crystals in the E-Ferol syndrome.
Brown RE; Alade SL; Krouse MA
JAMA; 1986 May; 255(18):2445. PubMed ID: 3701955
[No Abstract] [Full Text] [Related]
2. Oxalosis and the E-Ferol toxicity syndrome.
Conyers RA; Bais R; Rofe AM
JAMA; 1986 Nov; 256(19):2677-8. PubMed ID: 3773173
[No Abstract] [Full Text] [Related]
3. Lessons from the E-Ferol tragedy.
Balistreri WF; Farrell MK; Bove KE
Pediatrics; 1986 Sep; 78(3):503-6. PubMed ID: 3748688
[No Abstract] [Full Text] [Related]
4. Polysorbate 80 and E-Ferol toxicity.
Alade SL; Brown RE; Paquet A
Pediatrics; 1986 Apr; 77(4):593-7. PubMed ID: 3960626
[TBL] [Abstract][Full Text] [Related]
5. Polysorbate toxicity in neonatal rats and mice.
Farkas WR; Lorch V; Conover WR; al-Ansari HM; Abney LK; Painter PC; Reyniers JP; Congdon CC
Pharmacol Toxicol; 1991 Feb; 68(2):154-6. PubMed ID: 1852721
[No Abstract] [Full Text] [Related]
6. Mystery of the E-Ferol syndrome.
Nutr Rev; 1987 Mar; 45(3):76-7. PubMed ID: 3554028
[No Abstract] [Full Text] [Related]
7. More to the E-Ferol case than presented.
Ross SR
Am J Hosp Pharm; 1991 Sep; 48(9):1894-5. PubMed ID: 1928127
[No Abstract] [Full Text] [Related]
8. E-ferol: what happened and what now?
Phelps DL
Pediatrics; 1984 Dec; 74(6):1114-6. PubMed ID: 6504634
[No Abstract] [Full Text] [Related]
9. Vasculopathic hepatotoxicity associated with E-Ferol syndrome in low-birth-weight infants.
Bove KE; Kosmetatos N; Wedig KE; Frank DJ; Whitlatch S; Saldivar V; Haas J; Bodenstein C; Balistreri WF
JAMA; 1985 Nov; 254(17):2422-30. PubMed ID: 3930760
[TBL] [Abstract][Full Text] [Related]
10. Toxic susceptibilities in the newborn with special consideration of polysorbate toxicity.
Pesce AJ; McKean DL
Ann Clin Lab Sci; 1989; 19(1):70-3. PubMed ID: 2644892
[No Abstract] [Full Text] [Related]
11. Unusual syndrome among premature infants: association with a new intravenous vitamin E product.
Lorch V; Murphy D; Hoersten LR; Harris E; Fitzgerald J; Sinha SN
Pediatrics; 1985 Mar; 75(3):598-602. PubMed ID: 3975131
[TBL] [Abstract][Full Text] [Related]
12. Do you remember E-Ferol? The penalty for selling untested drugs in neonatology: fines and a jail sentence.
Lucey JF
Pediatrics; 1992 Jan; 89(1):159. PubMed ID: 1728005
[No Abstract] [Full Text] [Related]
13. [Free fatty acid levels and lipid peroxidation after exposure to cold and administration of alpha-tocopherol].
Linchevskaia AA; Iakhnina DN
Patol Fiziol Eksp Ter; 1986; (5):10-2. PubMed ID: 3797080
[No Abstract] [Full Text] [Related]
14. Illness with fatalities in premature infants: association with an intravenous vitamin E preparation, E-Ferol.
Martone WJ; Williams WW; Mortensen ML; Gaynes RP; White JW; Lorch V; Murphy MD; Sinha SN; Frank DJ; Kosmetatos N
Pediatrics; 1986 Oct; 78(4):591-600. PubMed ID: 3763266
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality among low birth weight infants exposed to an intravenous vitamin E product, E-Ferol.
Arrowsmith JB; Faich GA; Tomita DK; Kuritsky JN; Rosa FW
Pediatrics; 1989 Feb; 83(2):244-9. PubMed ID: 2492378
[TBL] [Abstract][Full Text] [Related]
16. Yellow nail syndrome.
Ayres S
Cutis; 1983 May; 31(5):493. PubMed ID: 6851644
[No Abstract] [Full Text] [Related]
17. alpha-Tocopherol influences tissue levels of vitamin A and its esters.
Nutr Rev; 1985 Feb; 43(2):55-6. PubMed ID: 3887238
[No Abstract] [Full Text] [Related]
18. Bioequivalence of RRR-alpha-tocopheryl acetate and all-rac-alpha-tocopheryl acetate.
Machlin LJ; Brin M
Am J Clin Nutr; 1981 Aug; 34(8):1633-6. PubMed ID: 7270489
[No Abstract] [Full Text] [Related]
19. Ratio of bioavailability of RRR-/all-rac-alpha-tocopherol.
Machlin LJ
Am J Clin Nutr; 1995 May; 61(5):1169-70. PubMed ID: 7733046
[No Abstract] [Full Text] [Related]
20. [Effectiveness of various pharmaceutical forms of alfa-tocopherol].
Paranich AV; Oleksieiev SM; Tarabrin MB; Gordonu Zh; Savchenko GV; Ortis L
Fiziol Zh (1978); 1993; 39(2-3):91-3. PubMed ID: 8405557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]